ArticleScientific reports2026
Factors associated with preterm birth and low birth weight among infants with congenital heart disease in Changsha City, China, 2022-2024.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to analyze the influencing factors for preterm birth (PTB) and low birth weight (LBW) among infants with congenital heart disease (CHD) in Changsha City and to provide a scientific basis for the development of targeted preventive measures. Data on infants with CHD were collected from all the birth defects (BDs) monitoring hospitals in Changsha City from January 1, 2022 to December 31, 2024. The diagnosis of BDs was coded according to the World Health Organization's International Classification of Diseases. CHD was classified under codes Q20-Q26 in the ICD-10. Multivariable binary logistic regression was used to identify factors associated with PTB and LBW among infants with CHD. 1,460 infants with CHD were included. The overall rates of PTB and LBW among infants with CHD were 15.89% and 14.38%, respectively. Maternal folic acid supplementation was identified as a protective factor for PTB in infants with CHD (aOR = 0.40, 95%CI: 0.23-0.67), while gestational diabetes mellitus (GDM) (aOR = 3.28, 95%CI: 1.44-7.48), and comorbidity with other BDs (aOR = 1.82, 95%CI: 1.36-2.44) were identified as risk factors. Minority ethnicity was identified as a protective factor for LBW among infants with CHD (aOR = 0.35, 95%CI: 0.14-0.89), while rural residence (aOR = 1.46, 95%CI: 1.02-2.08), history of spontaneous abortion (aOR = 1.96, 95%CI: 1.33-2.87), pregnancy-induced hypertension (aOR = 3.31, 95%CI: 1.03-10.67), female sex (aOR = 1.59, 95%CI: 1.18-2.16), and comorbidity with other BDs (aOR = 2.31, 95%CI: 1.70-3.13) were identified as risk factors. The rates of PTB and LBW among infants with CHD were relatively high in Changsha City. For PTB, maternal folic acid supplementation was a protective factor, whereas GDM and comorbidity with other BDs were risk factors. For LBW, minority ethnicity was a protective factor, whereas rural residence, history of spontaneous abortion, pregnancy-induced hypertension, female sex, and comorbidity with other BDs were risk factors. Further studies are needed to elucidate the determinants of PTB and LBW among infants with CHD, with analyses stratified by specific CHD subtypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.